Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/6810
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Coban, G. | - |
dc.contributor.author | Zencir, Sevil | - |
dc.contributor.author | Zupkó, I. | - |
dc.contributor.author | Réthy, B. | - |
dc.contributor.author | Gunes, H.S. | - |
dc.contributor.author | Topcu, Z. | - |
dc.date.accessioned | 2019-08-16T12:11:18Z | |
dc.date.available | 2019-08-16T12:11:18Z | |
dc.date.issued | 2009 | - |
dc.identifier.issn | 0223-5234 | - |
dc.identifier.uri | https://hdl.handle.net/11499/6810 | - |
dc.identifier.uri | https://doi.org/10.1016/j.ejmech.2008.06.018 | - |
dc.description.abstract | Benzimidazoles are important compounds because of their antibacterial, antifungal, antimicrobial, antiprotozoal and antihelmintic activities. Some benzimidazole derivatives also interfere with the reactions of DNA topoisomerases, enzymes functioning at almost all stages of the cell cycle. In this study, nine 1H-benzimidazole derivatives with substituents at positions 2 and 5 were synthesized and the structure of the compounds was elucidated by instrumental methods. The characterized compounds were screened to identify if they interfered with mammalian type I DNA topoisomerase activity via in vitro supercoil relaxation assays. Selected compounds were subjected to cytostatic assays using HeLa (cervix adenocarcinoma), MCF7 (breast adenocarcinoma) and A431 (skin epidermoid carcinoma) cells. Our results showed that 5-chloro-2-(2-hydroxyphenyl)-1H-benzimidazole exerted the most profound topoisomerase I inhibition and cytotoxicity. © 2008. | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | European Journal of Medicinal Chemistry | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | 1H-Benzimidazole derivatives | en_US |
dc.subject | MTT assay | en_US |
dc.subject | Plasmid Supercoil relaxation assays | en_US |
dc.subject | Synthesis | en_US |
dc.subject | Type I DNA topoisomerase | en_US |
dc.subject | 2 (1h benzimidazol 2 yl) phenol | en_US |
dc.subject | 2 (5 chloro 1h benzimidazol 2 yl)phenol | en_US |
dc.subject | 2 [2 (2 morpholin 4 ylethoxy)phenyl] 1h benzimidazole | en_US |
dc.subject | 2 [2 (2 piperidin 1 ylethoxy)phenyl] 1h benzimidazole | en_US |
dc.subject | 2 [2 (2 pyrrolidin 1 ylethoxy)phenyl] 1h benzimidazole | en_US |
dc.subject | 2 [2 (5 chloro 1h benzimidazol 2 yl)phenoxy] n,n diethylethanamine | en_US |
dc.subject | 5 chloro 2 (2 hydroxyphenyl) 1h benzimidazole | en_US |
dc.subject | 5 chloro 2 [2 (2 morpholin 4 ylethoxy)phenyl] 1h benzimidazole | en_US |
dc.subject | 5 chloro 2 [2 (2 piperidin 1 ylethoxy) phenyl] 1h benzimidazole | en_US |
dc.subject | 5 chloro 2 [2 (2 pyrrolidin 1 ylethoxy)phenyl] 1h benzimidazole | en_US |
dc.subject | benzimidazole derivative | en_US |
dc.subject | DNA topoisomerase | en_US |
dc.subject | doxorubicin | en_US |
dc.subject | unclassified drug | en_US |
dc.subject | article | en_US |
dc.subject | biological activity | en_US |
dc.subject | cancer cell | en_US |
dc.subject | cell strain MCF 7 | en_US |
dc.subject | controlled study | en_US |
dc.subject | cytostasis | en_US |
dc.subject | cytotoxicity | en_US |
dc.subject | drug screening | en_US |
dc.subject | drug structure | en_US |
dc.subject | drug synthesis | en_US |
dc.subject | enzyme activity | en_US |
dc.subject | enzyme assay | en_US |
dc.subject | enzyme inhibition | en_US |
dc.subject | HeLa cell | en_US |
dc.subject | human | en_US |
dc.subject | human cell | en_US |
dc.subject | IC 50 | en_US |
dc.subject | skin carcinoma | en_US |
dc.subject | squamous cell carcinoma | en_US |
dc.subject | Animals | en_US |
dc.subject | Antineoplastic Agents | en_US |
dc.subject | Benzimidazoles | en_US |
dc.subject | Cell Line, Tumor | en_US |
dc.subject | Cytostatic Agents | en_US |
dc.subject | DNA Topoisomerases, Type I | en_US |
dc.subject | Humans | en_US |
dc.subject | Structure-Activity Relationship | en_US |
dc.title | Synthesis and biological activity evaluation of 1H-benzimidazoles via mammalian DNA topoisomerase I and cytostaticity assays | en_US |
dc.type | Article | en_US |
dc.identifier.volume | 44 | en_US |
dc.identifier.issue | 5 | en_US |
dc.identifier.startpage | 2280 | |
dc.identifier.startpage | 2280 | en_US |
dc.identifier.endpage | 2285 | en_US |
dc.identifier.doi | 10.1016/j.ejmech.2008.06.018 | - |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.identifier.pmid | 18692939 | en_US |
dc.identifier.scopus | 2-s2.0-62549162118 | en_US |
dc.identifier.wos | WOS:000265339900058 | en_US |
dc.identifier.scopusquality | Q1 | - |
dc.owner | Pamukkale University | - |
item.grantfulltext | none | - |
item.fulltext | No Fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.openairetype | Article | - |
item.cerifentitytype | Publications | - |
item.languageiso639-1 | en | - |
crisitem.author.dept | 14.03. Basic Medical Sciences | - |
Appears in Collections: | PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
CORE Recommender
SCOPUSTM
Citations
52
checked on Jan 4, 2025
WEB OF SCIENCETM
Citations
50
checked on May 12, 2025
Page view(s)
90
checked on May 12, 2025
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.